Abstract
Drug research increasingly focuses on the interference with protein-protein interface formation as attractive opportunity for therapeutic intervention. The tRNA-modifying enzyme Tgt, a putative drug target to fight Shigellosis, is only functionally active as a homodimer. To better understand the driving forces responsible for assembly and stability of the formed homodimer interface we embarked onto a computational and mutational analysis of the interface-forming residues. We also launched spiking ligands into the interface region to perturb contact formation. We controlled by non-degrading mass spectrometry the actual ratio of monomer-dimer equilibrium in solution and used crystal structure analysis to elucidate the geometrical changes resulting from the induced perturbance. A patch of four aromatic amino acids, embedded into a ring of hydrophobic residues and further stabilized by a network of H-bonds is essential for the dimer contact. Apart from the aromatic hot spot, the interface shows an extended loop-helix motif, which exhibits remarkable flexibility. In the destabilized mutant variants and the complexes with the spiking ligands, the loop-helix motif adopts deviating conformations in the interface region. This motivated us to follow a strategy to raise small molecule binders against this motif to mould the loop geometry in a conformation incompatible with the interface formation.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Klebe G (2013) Drug design, Chapter 21, Springer Reference, Heidelberg, New York, Dordrecht, London. doi:10.1007/978-3-642-17907-5
Romier C, Ficner R, Reuter K, Suck D (1996) Purification, crystallization, and preliminary x-ray diffraction studies of tRNA-guanine transglycosylase from Zymomonas mobilis. Proteins Struct Funct Genet 24:516–519
Grädler U, Gerber HD, Goodenough-Lashua DM, Garcia GA, Ficner R, Reuter K, Stubbs MT, Klebe G (2001) A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. J Mol Biol 306:455–467
Stengl B, Reuter K, Klebe G (2005) Mechanism and substrate specificity of tRNA – guanine transglycosylases (TGTs): tRNA modifying enzymes from thee three different kingdoms of life seem to share a common mechanism. ChemBioChem 6:1–15
Brenk R, Naerum L, Grädler U, Gerber HD, Garcia GA, Reuter K, Stubbs MT, Klebe G (2003) Virtual screening for submicromolar leads of TGT based on a new unexpected binding mode detected by crystal structure analysis. J Med Chem 46:1133–1143
Meyer EA, Donati N, Guillot M, Schweizer B, Diederich F, Stengl B, Brenk R, Reuter K, Klebe G (2006) Synthesis, biological evaluation, and crystallographic studies of extended guanine-based (lin-benzoguanine) inhibitors for tRNA-guanine transglycosylase (TGT). Helv Chim Acta 89:573–597
Hörtner S, Ritschel T, Stengl B, Kramer C, Klebe G, Diederich F (2007) Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding. Angew Chem Int Ed 46:8266–8269
Ritschel T, Kohler PC, Neudert G, Heine A, Diederich F, Klebe G (2009) How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase. ChemMedChem 4:2012–2023
Kohler PC, Ritschel T, Schweizer WB, Klebe G, Diederich F (2009) High-affinity inhibitors of tRNA-guanine transglycosylase replacing the function of a structural water cluster. Chem Eur J 15:10809–10817
BarandunL IF, Kohler PC, Ritschel T, Heine A, Orlando P, Klebe G, Diederich F (2013) High-affinity inhibitors of Zymomonas mobilis tRNA–guanine transglycosylase through convergent optimization. Acta Crystallogr D69:1798–1807
Stengl B, Meyer EA, Heine A, Brenk R, Diederich F, Klebe G (2007) Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding. J Mol Biol 370:492–511
Xie W, Liu X, Huang RH (2003) Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate. Nat Struct Biol 10:781–788
Ritschel T, Atmanene C, Reuter K, Van Dorsselaer A, Sanglier-Cianferani S, Klebe G (2009) An integrative approach combining noncovalent mass spectrometry, enzyme kinetics and X-ray crystallography to decipher Tgt protein-protein and protein-RNA interaction. J Mol Biol 393:833–847
Gohlke H, Kiel C, Case DA (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol 330:891–913
Jakobi S, Nguyen TXP, Debaene F, Metz A, Sanglier-Cianferani S, Reuter K, Klebe G (2014) Hot-spot analysis to dissect the functional protein–protein interface of a tRNA-modifying enzyme. Proteins Struct Funct Bioinform 82:2713–32
Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280:1–9
Immekus F, Barandun LJ, Betz M, Debaene F, Petiot S, Sanglier-Cianferani S, Reuter K, Diederich F, Klebe G (2013) Launching spiking ligands into a protein–protein interface: a promising strategy to destabilize and break interface formation in a tRNA modifying enzyme. ACS Chem Biol 8:1163–1178
Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein–protein interactions: progressing towards the dream. Nat Rev Drug Discov 3:301–317
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Klebe, G. (2015). Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition. In: Scapin, G., Patel, D., Arnold, E. (eds) Multifaceted Roles of Crystallography in Modern Drug Discovery. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9719-1_16
Download citation
DOI: https://doi.org/10.1007/978-94-017-9719-1_16
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9718-4
Online ISBN: 978-94-017-9719-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)